Frequency of prophylaxia for venous tromboembolism in the FHGCV
DOI:
https://doi.org/10.4322/prmj.2017.002Keywords:
venous thrombosis, enoxaparin, prophylaxisAbstract
Objective: To identify the frequency of the use of prophylaxis for deep venous thrombosis and to compare the use of prophylaxis for DVT in the Medical and Surgical Clinic of the FHCGV. Method: Cross-sectional and descriptive study, in the period from October to October 2016, involving 38 patients, 29 clinical and 9 surgical. Data were collected from medical records and prescriptions. Patients were stratified according to the risk of venous thromboembolism (using Kucher’s modified Padua score for clinical patients and the Caprini score for surgical patients). We defined the presence of adequate or inadequate prophylaxis for VTE following the international recommendations of the American College of Chest Physicians. Results: A frequency of prophylaxis for VTE was found to be 100%, since all patients were receiving some form of prophylaxis, medication and/or non-medication. However, when analyzing the suitability of the prophylaxis according to the risk group and the recommendations for prophylaxis, we found that 5 patients (55.56%) had adequate prophylaxis in the surgical group, and 4 patients (44.44%) had adequate prophylaxis, Inadequate. In the clinical group, it was observed that 14 patients (48.28%) presented adequate prophylaxis and 15 (51.72%), inadequate. There was no significant trend between groups (p> 0.05). Conclusion: It was possible to observe that among the patients analyzed, none of them did not receive prophylaxis for VTE; however, when stratifying the risks, it was noted that the patients in the medium and low risk groups were those who most frequently received inadequate prophylaxis, whereas among the patients High risk were those who received adequate prophylaxis more frequently. We could conclude that it is very important to establish protocols based on the profile of the institution, thus improving patient care.
Downloads
References
GOLDHABER SZ. Trombose venosa profunda e tromboembolia pulmonar. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, et al. Medicina interna de Harrison. 18. ed. Porto Alegre: Artmed; 2013. p. 170-77.
GEERTS WH, BERGQVIST D, PINEO GF, HEIT JA, SAMAMA CM, LASSEN MM, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice in Guidelines (8th edition). Chest. 2008;133(6):381S-453S.
BRANDÃO No RA. Trombose venosa profunda. In: Emergências clinicas: abordagem prática. 8. ed. São Paulo: Manole; 2013. p. 713-24.
SAAD PF, NESER RA, SAAD Jr R. Tromboembolismo venoso. Colégio Brasileiro de Cirurgiões. Programa de Auto-avaliação em Cirurgia. 2004;3:4-17.
WHITE RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):4-8. PMid:12814979.
KAHN SR, HIRSCH A, SHRIER I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162(10):1144-8. PMid:12020185. http://dx.doi.org/10.1001/archinte.162.10.1144.
MAFFI FHA, ROLLO HA. Trombose venosa profunda dos membros inferiores: incidência, patologia, patogenia, fisiopatologia e diagnóstico. In: Maffi FHA, Lastória S, Yoshida WB, Rollo HA. Doenças vasculares periférica. 3. ed. Rio de Janeiro: MEDSI; 2002.
MAFFI FHA, CAIAFA JS, RAMACCIOTTI E, CASTRO AA. Grupo de Elaboração de Normas de Orientação Clínica em Trombose Venosa Profunda da SBACV. Normas de orientação clínica para prevenção, diagnóstico e tratamento da trombose venosa profunda (revisão 2005). Salvador: SBACV; 2005 [citado em 2016 maio 15]. Disponível em: <http://www.jvascbr.com.br/Arquivo_4.pdf>.
BARRETO SSM, ALBUQUERQUE GC. Tromboembolia pulmonar aguda. In: Lopes AC. Tratado de Clínica Médica. 2. ed. São Paulo: Roca. Cap 246, p. 2720-35. vol 2.
CAPRINI JÁ, TAPSON VF, HYERS TM, WALDO AL, WITTKOWSKY AK, FRIEDMAN R, et al. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005;42(4):726-33. PMid:16242561. http://dx.doi.org/10.1016/j.jvs.2005.05.053.
ARNOLD DM, KAHN SR, SHRIER I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001;120(6):1964-71. PMid:11742929. http://dx.doi.org/10.1378/chest.120.6.1964.
GARCIA ACF, SOUZA BV, VOLPATO DE, et al. Realidade do uso da profilaxia para trombose venosa profunda: da teoria à prática. J Vasc Bras. 2005;4(1):35-41.
PITTA GBB, LEITE TL, SILVA MDC, MELO CFL, CALHEIROS GA. Avaliação da utilização de profilaxia da trombose venosa profunda em um hospital escola. J Vasc Bras. 2007;6(4):344-51. http://dx.doi.org/10.1590/S1677-54492007000400008.
GUYATT GH, EIKELBOOM JW, GOULD MK, GARCIA DA, Crowther M, Murad MH, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e185S-e194S.
PITTA GBB, GOMES RR. A frequência da utilização de profilaxia para trombose venosa profunda em pacientes clínicos hospitalizados. J Vasc Bras. 2010;9(4):220-8. http://dx.doi.org/10.1590/S1677-54492010000400003.
CAPRINI JA, ARCELUS JI, REYNA JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001;38(2 Suppl 5):12-9. PMid:11449339. http://dx.doi.org/10.1053/shem.2001.25184.
KUCHER N, KOO S, QUIROZ R, COOPER JM, PATERNO MD, SOUKONNIKOV B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969-77. PMid:15758007. http://dx.doi.org/10.1056/NEJMoa041533.
ALCKMIN CAV, GARCIA MD, BRICOLA SAPC, MARTINS MA, LICHTENSTEIN A, PAIVA EF. Venous Thromboembolism risk assessment in hospitalized patients: a new proposal. Clinics. 2013;68(11):1416-20. PMid:24270953. http://dx.doi.org/10.6061/clinics/2013(11)06.
ROCHA AT, BRAGA P, RITT G, LOPES AA. Inadequacy off thromboprophylaxis in hospitalized medical matients. Rev Assoc Med Bras. 2006;52(6):441-6. PMid:17242783. http://dx.doi.org/10.1590/S0104-42302006000600026.
DEHEINZELIN D, BRAGA AL, MARTINS LC, MARTINS MA, HERNANDEZ A, YOSHIDA WD, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006;4(6):1266-70. PMid:16706970. http://dx.doi.org/10.1111/j.1538-7836.2006.01981.x.
MARTINO MA, BORGES E, WILLIAMSON E, SIEGFRIED S, CANTOR AB, LANCASTER J, et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol. 2006;107(3):666-71. PMid:16507939. http://dx.doi.org/10.1097/01.AOG.0000200046.28199.ae.
OKUHARA A, NAVARRO TP, PROCÓPIO RJ, Bernardes RC, Oliveira LCC, Nishiyama MP. Incidência de trombose venosa profunda e qualidade da profilaxia para tromboembolismo venoso. Rev Col Bras Cir. 2014;41(1):2-6.
VAZQUEZ F, WATMAN R, TABARES A, GUMPEL C, BALDESSARI E, VILASECA AB, et al. Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study. Thromb J. 2014;12:15. PMid:25024645. http://dx.doi.org/10.1186/1477-9560-12-15.
COHEN AT, TAPSON VF, BERGMANN JF, GOLDHABER SZ, KAKKAR AK, DESLANDES B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008 fev 2;371(9610):387-94. PMid:18242412. http://dx.doi.org/10.1016/S0140-6736(08)60202-0.

